Marché mondial de l’hydronéphrose – Tendances et prévisions de l’industrie jusqu’en 2031

Analyse et taille du marché de l'hydronéphrose

Le marché mondial de l'hydronéphrose connaît une croissance tirée par une sensibilisation croissante, des progrès dans la technologie médicale et des incidences croissantes d'obstructions des voies urinaires. L'hydronéphrose, caractérisée par un gonflement des reins dû à l'accumulation d'urine, touche un nombre important de personnes dans le monde, avec des causes diverses, notamment des calculs rénaux , des tumeurs ou des anomalies congénitales. L'expansion du marché est également propulsée par des innovations diagnostiques telles que l'échographie, la tomodensitométrie et l'IRM, facilitant la détection précoce et la planification du traitement. De plus, les interventions chirurgicales telles que la pose d'un stent urétéral et la néphrostomie sont des traitements clés, garantissant un soulagement des symptômes et préservant la fonction rénale.

Français La taille du marché mondial de l'hydronéphrose a été évaluée à 3,22 milliards USD en 2023 et devrait atteindre 6,72 milliards USD d'ici 2031, avec un TCAC de 9,64 % au cours de la période de prévision de 2024 à 2031. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée du rapport et segmentation du marché       

Market Definition

Hydronephrosis is a medical condition characterized by the swelling or dilation of one or both kidneys due to a buildup of urine. This occurs when there is an obstruction or blockage in the urinary tract, preventing urine from draining properly from the kidney to the bladder. The obstruction can be caused by various factors, such as kidney stones, congenital abnormalities, tumors, or scarring from previous infections.   

Hydronephrosis Market Dynamics

Drivers

• Increasing Prevalence of Hydronephrosis   

The prevalence of hydronephrosis is steadily increasing globally, primarily due to rising incidences of urinary tract obstructions and various kidney disorders. Factors such as kidney stones, tumors, congenital anomalies, and infections contribute significantly to the development of hydronephrosis. The condition affects individuals of all ages but is particularly prevalent among adults and elderly populations. As lifestyles evolve, dietary habits change, and chronic conditions like diabetes and hypertension become more widespread, the risk factors for urinary tract complications and kidney-related disorders increase, driving the market growth.  

• Growing Geriatric Population Prone to Kidney-Related Disorders  

The global demographic shift towards an aging population has led to a heightened susceptibility to kidney-related disorders, including hydronephrosis. Elderly individuals often experience physiological changes that affect kidney function, such as decreased renal blood flow and diminished ability to concentrate urine. These factors, coupled with the prevalence of chronic diseases like diabetes and hypertension among the elderly, contribute to an increased incidence of hydronephrosis. As the elderly population continues to grow, healthcare providers face greater demands in managing and treating kidney-related conditions effectively, driving the market growth.

Opportunities

• Rising Healthcare Expenditure     

Recent advancements in the treatment of hydronephrosis have revolutionized patient care, offering more effective and less invasive options for management. Minimally invasive surgical procedures, such as ureteral stenting and nephrostomy, have become standard practice in relieving urinary tract obstructions and restoring kidney function. These procedures not only reduce recovery times and hospital stays but also minimize the risk of complications compared to traditional open surgeries. Moreover, pharmaceutical therapies aimed at addressing underlying causes of hydronephrosis, such as medications to dissolve kidney stones or manage infections, have improved patient outcomes significantly, creating opportunities for market growth. 

• Advancements in Treatment Options for Hydronephrosis     

The global rise in healthcare expenditure reflects increasing investments in infrastructure, technology, and patient care, which are pivotal in addressing complex medical conditions like hydronephrosis. Governments and private sectors are allocating substantial resources towards improving healthcare accessibility and quality, particularly in developing regions where infrastructure gaps exist. This surge in funding supports the expansion of healthcare facilities, procurement of advanced medical equipment, and training of healthcare professionals specializing in kidney-related disorders. In addition, higher healthcare spending fosters research and development initiatives aimed at discovering innovative treatments and diagnostic tools for hydronephrosis.  These are creating significant market opportunities, reducing the burden of kidney-related diseases on individuals and societies alike.

Restraints/Challenges

• Adverse Effects of Medications and Surgical Interventions 

While advancements in hydronephrosis treatment offer significant benefits, they also come with potential risks and side effects that patients and healthcare providers must consider. Medications prescribed for managing kidney stones or infections may cause adverse reactions such as gastrointestinal upset or allergic responses in some individuals. Similarly, surgical interventions like ureteral stenting or nephrostomy carry risks of complications such as infection, bleeding, or damage to surrounding tissues. These potential side effects underscore the importance of thorough risk assessment and patient counselling before initiating treatment.  

• Regulatory Requirements for New Medical Devices and Treatments        

Navigating the regulatory landscape presents significant challenges for companies developing new medical devices and treatments for hydronephrosis. Stringent regulatory requirements, varying across different regions and countries, necessitate extensive clinical trials, safety evaluations, and documentation to obtain approvals. These processes aim to ensure the efficacy, safety, and quality of healthcare products before they reach the market and are used in patient care. However, the lengthy approval timelines and resource-intensive nature of regulatory compliance can pose barriers to innovation and market entry for smaller companies or start-ups.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In August 2023, Novartis announced the successful acquisition of Chinook Therapeutics, Inc., a biopharmaceutical company headquartered in Seattle, WA. Chinook Therapeutics specializes in the research, development, and commercialization of precision medicines targeting kidney diseases

Hydronephrosis Market Scope

The market is segmented on the basis of indication, treatment, type, and diagnosis. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indication

• Intrinsic
  • Acute Unilateral Obstructive Uropathy
  • Kidney Stone
  • Bladder Cancer
  • Bladder Stones
  • Cystocele
  • Urethral Stricture
  • Urethral Cancer
  • Others
• Extrinsic
  • Retroperitoneal Fibrosis
  • Ovarian Vein Syndrome
  • Cancer of the Cervix
  • Cancer of the Prostate
  • Uterine Prolapse
  • Prostate Cancer
  • Pregnancy
  • Others

Treatment

• Shock Wave Lithotripsy
• Laparoscopy
• Bladder Catheterization
• Steroid Therapy
• Others

Type

• Unilateral Hydronephrosis
• Bilateral Hydronephrosis

Diagnosis

• Laboratory Test
  • Urinalysis
  • Complete Blood Count
  • Electrolyte Analysis
  • Others
• Imaging
  • CT Scan Ultrasound
  • Intravenous
  • Pyelography
  • KUB X-Rays
  • Others

Hydronephrosis Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, indication, treatment, type, and diagnosis as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to increased expenditure on research and development, substantial healthcare spending, a higher prevalence of kidney-related disorders, the presence of key market players, and the introduction of technologically advanced products in these regions.   

L'Asie-Pacifique devrait connaître une croissance significative au cours de la période de prévision en raison de l'augmentation des dépenses publiques dans le secteur de la santé, de l'augmentation de la population gériatrique, en particulier dans les économies émergentes comme l'Inde et la Chine, et de l'augmentation du revenu personnel disponible. 

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces de Porter, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.

Croissance de la base installée des infrastructures de santé et pénétration des nouvelles technologies

Le marché vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les biens d'équipement, la base installée de différents types de produits pour le marché, l'impact de la technologie à l'aide de courbes de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché. Les données sont disponibles pour la période historique 2016-2021.

Analyse du paysage concurrentiel et des parts de marché de l'hydronéphrose

Le paysage concurrentiel du marché fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises par rapport au marché.

Certains des principaux acteurs opérant sur le marché sont :

• Allergan (Irlande)
• Amgen Inc. (États-Unis)
• Sanofi (France)
• Novartis SA (Suisse)
• Pfizer Inc. (États-Unis)
• F. Hoffmann-La Roche SA (Suisse)
• Teva Pharmaceutical Industries Ltd. (Israël)
• Boston Scientific Corporation (États-Unis)
• B. Braun Melsungen AG (Allemagne)
• Stryker (États-Unis)
• Zimmer Biomet (États-Unis)
• Smith & Nephew plc (Royaume-Uni)
• Promega Corporation (États-Unis)
• Sigma-Aldrich Co. (États-Unis)
• Thermo Fisher Scientific Inc. (États-Unis)
• Bio-Rad Laboratories, Inc. (États-Unis)

SKU-13210